These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31852078)
1. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study. Zhao S; Jia X; Fan X; Zhao L; Pang P; Wang Y; Luo Y; Wang F; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Ba J; Dou J; Mu Y; Lyu Z Medicine (Baltimore); 2019 Dec; 98(50):e18213. PubMed ID: 31852078 [TBL] [Abstract][Full Text] [Related]
2. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713 [TBL] [Abstract][Full Text] [Related]
3. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452 [TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors. Li CL; Dionigi G; Zhao YS; Liang N; Sun H J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701 [TBL] [Abstract][Full Text] [Related]
5. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study. Dong Z; Liu W; Su F; Cheng R Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471 [TBL] [Abstract][Full Text] [Related]
6. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study. Wu C; Wang L; Chen W; Zou S; Yang A Medicine (Baltimore); 2017 Mar; 96(9):e6202. PubMed ID: 28248875 [TBL] [Abstract][Full Text] [Related]
7. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan. Zaman SU; Awan MS; Sulaiman MA Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545 [TBL] [Abstract][Full Text] [Related]
8. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
9. Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study. Kim M; Kang YE; Park YJ; Koo BS; Ku EJ; Choi JY; Lee EK; Kim BH Endocrine; 2023 Oct; 82(1):134-142. PubMed ID: 37516686 [TBL] [Abstract][Full Text] [Related]
10. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients. Handelsman RS; Alvarez AL; Picado O; Farrá JC; Lew JI J Surg Res; 2019 Dec; 244():96-101. PubMed ID: 31280000 [TBL] [Abstract][Full Text] [Related]
11. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma. Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082 [TBL] [Abstract][Full Text] [Related]
12. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes. Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737 [TBL] [Abstract][Full Text] [Related]
15. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422 [TBL] [Abstract][Full Text] [Related]
16. Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis. Economides A; Giannakou K; Mamais I; Economides PA; Papageorgis P Front Endocrinol (Lausanne); 2021; 12():692879. PubMed ID: 34276564 [TBL] [Abstract][Full Text] [Related]
17. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997 [TBL] [Abstract][Full Text] [Related]
18. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies. Xu L; Port M; Landi S; Gemignani F; Cipollini M; Elisei R; Goudeva L; Müller JA; Nerlich K; Pellegrini G; Reiners C; Romei C; Schwab R; Abend M; Sturgis EM Thyroid; 2014 Jun; 24(6):966-74. PubMed ID: 24555500 [TBL] [Abstract][Full Text] [Related]
19. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer. Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841 [TBL] [Abstract][Full Text] [Related]
20. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm. Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]